Skip to main content

Author: Johnny Green

How Reliable Is Cannabis DUII Technology?

One of the most common talking points for cannabis opponents is the claim that if cannabis laws are reformed there will be mayhem on public roadways.

The ‘stoned driver epidemic’ doomsday prediction is very popular among people and organizations that campaign and lobby against cannabis reform all over the globe.

No country is immune to the phenomenon. If cannabis reform is being explored, cannabis opponents will come from all over the place to parrot this talking point.

With more countries successfully implementing cannabis reform policies, this talking point is becoming less effective since the doomsday predictions are not becoming reality.

However, cannabis is still an intoxicating substance, and driving under the influence is a very serious issue that deserves constructive conversations and solutions that are based on science.

As countries around the world try to adopt sensible ways to prevent cannabis DUIIs, breathalyzer technology is a popular option for international lawmakers. 

Cannabis Breathalyzers – Effective Technology Or Junk Science?

People that are not familiar with cannabis science often make the false assumption that cannabis intoxication can be effectively measured using a breathalyzer device.

It’s easy to understand why people make that false assumption. After all, breathalyzer technology is very effective at determining if a person is too intoxicated from alcohol consumption to safely operate a motor vehicle on a public roadway.

Unfortunately, the same is not true for cannabis consumption.

All cannabis breathalyzers on the market right now can detect the presence of cannabis, yet they cannot determine if the subject of the breathalyzer is intoxicated or not at the time of the test.

Cannabis affects different people in different ways. An infrequent cannabis user can consume an edible with 5 mgs of THC in it and be too impaired to safely operate a motor vehicle.

A user that consumes cannabis on a frequent basis can consume significantly more than 5 mgs of THC and be able to easily operate a motor vehicle in a safe manner.

Cannabis stays in a person’s system for a long time, especially when the person is a frequent cannabis consumer. 

A breathalyzer may detect cannabis use by a person that occurred well before the person operated a motor vehicle. 

Conversely, a breathalyzer may not detect cannabis use by a newbie since the driver consumed such a small amount of THC, even though the driver may be too impaired to drive at the time of the test.

Canadian Researchers Look At Cannabis Impairment And Motor Vehicle Operation

A group of researchers in Canada recently conducted a double-blind, placebo-controlled clinical trial in which cannabis consumers ‘were randomized with a 2:1 allocation ratio to receive active (12.5% THC) or placebo (0.009% THC) cannabis.’ 

Study participants were then split into two groups – low and high THC, as measured by concentrations of THC in their blood at the time of the trial. 

The participants then performed simulated driving tasks and were assessed 30 minutes, 24 hours, and 48 hours after consuming cannabis.

Researchers concluded the following:

Ninety-six participants were randomized, and 91 were included in the final analysis (30 high THC, 31 low THC, 30 placebo). Mean speed (but not lateral control) significantly differed between groups 30 minutes after smoking cannabis (p ≤ 0.02); low and high THC groups decreased their speed compared to placebo. Heart rate, VAS drug effect and drug high increased significantly immediately after smoking cannabis and declined steadily after that. There was little evidence of residual effects in any of the measures.

The lack of residual effects from cannabis consumption on the drivers in the trial is significant from a DUI policy perspective.

If a cannabis breathalyzer only measures the presence of THC, and not how long ago the consumption occurred or if the consumption caused impairment, the breathalyzer results are basically useless.

Proving Impairment Is Vital For Effective Public Policy And Safety

Responsible members of society want their public roadways to be safe, and responsible cannabis consumers are a subset of that group.

A responsible cannabis consumer does not operate a motor vehicle when impaired and does not want to be lumped in with irresponsible cannabis consumers that get behind the wheel when they shouldn’t.

Because of that, responsible cannabis consumers are helping lead the charge when it comes to developing effective ways of detecting cannabis impairment.

Simply detecting whether or not cannabis use has occurred is not enough. The same is true for measuring metabolized THC in a person’s system.

A much more effective approach is conducting field sobriety tests in a way that incorporates effective technology.

An example of such technology is the Canary App which was developed by NORML. The Canary app ‘combines decades of research and experience, specialized mental and physical performance tests, and sophisticated analysis to accurately measure impairment due to alcohol, medication, fatigue and even the subtle impact of marijuana.’

Performance test technology accounts for a person’s cannabis tolerance level and measures cannabis impairment far more accurately than a breathalyzer that merely detects the presence of THC.

Cannabis DUI laws need to be based on science, not political views, and the technology used by enforcement agencies around the world is obviously part of that.

As lawmakers in countries around the globe continue to explore cannabis reform, effective cannabis DUI detection technology needs to be a top priority.

Paraguay Legalizes Industrial Hemp

The global industrial hemp market is currently estimated to be worth nearly five billion dollars (USD). By 2025, it is projected to be worth over $26 billion dollars (USD).

For a number of years, the industrial hemp industry was significantly limited by prohibition policies all over the globe. Fortunately, things have changed in recent years.

A number of countries around the world still prohibit hemp production, however, a growing list of countries are allowing farmers to legally cultivate the versatile plant, with the latest being the nation of Paraguay. Per La Nacion:

On Monday, the Executive Branch announced that President Mario Abdo signed the regulatory decree for the controlled production of industrial hemp or cannabis. It establishes that family farming producers can grow it.

The policy change allows every family in Paraguay to cultivate up to a maximum of two hectares of low-THC industrial hemp. Two hectares equates to slightly under 5 acres.

How Much Money Can A Family In Paraguay Make From Cultivating Hemp?

Each hectare of industrial hemp in Paraguay is valued at roughly 10,000,000 Paraguayan Guarani, which converts to roughly $1,545.00 USD.

If a family in Paraguay can successfully cultivate and harvest 2 industrial hemp crops annually, that’s a significant income boost considering the per capita GDP in Paraguay ($9,826 USD).

Paraguay’s industrial hemp industry model is very interesting in that it is built on a cottage industry model.

Out of a population of roughly 7 million people, it is estimated that as many as 25,000 families will take advantage of the recent policy change.

How Popular Will Hemp Cultivation Be In Paraguay?

How widespread hemp cultivation ultimately proves to be will largely depend on how profitable it is for families.

For families who live in areas with rich soil and a climate that is suitable for proper hemp cultivation, the 2-hectare limit may prove to be too low. For families who live in less ideal areas, reaching the cultivation limit may never be a concern.

The hemp plant will grow just about anywhere, however, to grow in a manner that yields a desirable harvest the hemp plant needs good soil and a mild climate.

Technology can help increase yields and quality, although it may be tough for some families to afford sophisticated cultivation equipment and light deprivation greenhouses in Paraguay.

Demand For Hemp Will Continue To Increase

The hemp plant is one of the most versatile plants on earth, with tens of thousands of products being able to be made from it.

In recent years the popularity of CBD, which the hemp plant is rich in, has exploded all over the planet. 

Demand for CBD products is what is going to drive the hemp industry forward, in Paraguay and beyond. Consumer demand for hemp-derived CBD will definitely increase, including CBD derived from industrial hemp from Paraguay.

However, whether or not families in Paraguay will reap the rewards will have to be seen as time goes along. 

Comparatively, farmers in the United States are making tens of thousands of dollars per hectare from hemp. The estimated value for hemp in Paraguay is considerably less. 

Hopefully Paraguayan families get an equitable share of any profits generated by Paraguay’s hemp industry. If not, Paraguay’s industrial hemp industry will never reach its full potential.

Trump Administration Approves Proposed USDA Hemp Rules

The United States is undergoing a hemp revolution, largely driven by the explosion in CBD’s popularity. Industrial hemp is still popular, however, floral hemp has experienced exponential growth in popularity across the country in recent years.

According to Vote Hemp, 511,442 acres of hemp were licensed for cultivation in 2019 in the United States, more than quadrupling the amount of licensed acreage compared to 2018. A limited removal of federal hemp prohibition occurred via the 2014 Farm Bill which allowed states to launch hemp research and/or pilot programs.

Some states took advantage of the public policy change, while others did not.

Hemp policy evolved dramatically after the passage of the 2018 Farm Bill which included a provision for hemp legalization nationwide. Since that time it seems as if farmers across the U.S. have scrambled to plant as much hemp as they can in an attempt to cash in on the newly allowed agriculture crop.

The United States Department of Agriculture (USDA) has worked towards crafting and adopting rules ever since the 2018 Farm Bill’s passage. The USDA effort passed a major milestone this week, as reported by Marijuana Moment:

The White House approved plans to regulate hemp and its derivatives on Friday, signing off on interim final rules for the crop that were submitted by the U.S. Department of Agriculture (USDA).

USDA has been working to develop hemp regulations since the crop was federally legalized under the 2018 Farm Bill in December. A top official with the department said earlier this month that rules would be released within weeks and, since then, the White House Office of Management and Budget (OMB) has finalized its review of the proposal.

The rules are not public yet, however, they are expected to be released for public comment soon. In these truly divisive times, hemp policy is one of the few areas that both major political parties seem to be able to agree on.

The proposed rules are expected to involve THC limit standards, testing protocols, and a range of other regulations that will govern the emerging hemp industry in the United States going forward.

Germany Is Exploring Cannabis Legalization Reform

Uruguay was the first country to legalize cannabis for adult-use, followed by Canada. A Supreme Court ruling in Mexico declared cannabis prohibition unconstitutional in that country, which makes Mexico essentially the third country to legalize cannabis for adult use.

Many political observers have speculated that the European nation of Luxembourg will be the next to legalize cannabis, however, Luxembourg may not be the first to legalize on the European continent. A report recently surfaced stating that German lawmakers (Chancellor of Germany Angela Merkel’s political party) are giving strong consideration to legalization. Per DW:

Germany’s center-right Christian Democratic Union (CDU) is openly considering a momentous u-turn in the party’s attitude to the legalization of cannabis.

“Cannabis could be freed for personal use, of course with controlled production and distribution,” CDU interior policy spokesman Marian Wendt told the RND network on Friday. “The resources freed in the police and judiciary should be used to fight the illegal trade.”

The implementation process of cannabis legalization in Uruguay and Canada has had its ups and downs, but for the most part, it has been successful. Whether that would prove to be the case in Germany would largely depend on the legalization model it adopts.

The unregulated cannabis market will likely always exist in Germany, just as it will likely exist in other countries that move to legalize cannabis for adult use. However, that’s not to say that legalization won’t be worth it in Germany and that the continued existence of an unregulated cannabis market (or not) should be the only measure of success.

Freeing up law enforcement to investigate and prosecute real crime in Germany is in itself worth it to legalize cannabis for adult use, as is refraining from ruining people’s lives because they were in possession of a plant that is safer than alcohol. A thriving regulated cannabis industry is another huge benefit.

Prohibition Partners recently released a projection for Germany’s cannabis industry putting the size of Germany’s legal cannabis industry at over $16 billion by 2028. That projection was based in part on the assumption that Germany would legalize cannabis for adult use between now and 2028. It’s quite possible that legalization could come sooner rather than later to Germany.

France Approves Funding For Two Years Of Medicinal Cannabis Research

France is one of the least progressive countries in Europe when it comes to cannabis policy. France is one of the few remaining countries in Europe that completely prohibits medical cannabis. However, that could be changing.

On Friday lawmakers in France voted to approve funding for a two-year medical cannabis research project. Per The Local:

Olivier Veran, a lawmaker from President Emmanuel Macron’s centrist party who proposed the budget inclusion, said the experiments could target some 3,000 sick people in France.

They will seek to determine whether cannabis derivatives can alleviate the symptoms of certain illnesses, and in which doses, he said.

Seventeen other European Union members have already authorised cannabis-based therapies, he added.

The list of health conditions that will reportedly be a part of the study will include epilepsy, chronic pain, cancer, and multiple sclerosis. The study will not involve inhaled-forms of cannabis. Rather, participants will consume cannabis-derived medical products via capsules and other oral dosing methods.

The medical cannabis experiments in France are certainly better than nothing, however, the study is limited in size compared to others that will be conducted on the European continent in the near future.

Earlier this month a medical cannabis study was announced in the UK which will involve 145,000 patients and will be narrowly focused on whether CBD is an effective treatment for Parkinson’s disease.

Still, the approval for medical cannabis research funding in France is significant and will hopefully lead to an increase in future research and help build momentum for medical cannabis reform in France.

UK Researchers To Examine Whether CBD Can Help Parkinson’s Patients

Scientists in the UK have announced that they will be launching the largest study to date that looks at cannabidiol (CBD) and if it can be an effective treatment for Parkinson’s disease.

Over 10 million people worldwide suffer from Parkinson’s. A number of personal patient experiences suggest that the cannabis plant can be an effective treatment for Parkinson’s, however, a lot of questions have so far gone unanswered from a research standpoint.

Hopefully the results of this study will help reduce the stigma associated with cannabis, be used as a foundation for continued research, and ultimately help patients across the globe that suffer from Parkinson’s.

To learn more about what the study will involve, including how many patients will be participating, check out our article on Cannabis & Tech Today.

Finland’s Government To Consider Decriminalizing Cannabis

Cannabis advocates in Finland have gathered enough signatures for a cannabis decriminalization petition to require a review of the proposal by Finland’s Parliament. 50,000 petition signatures were required to require the review.

As described by Marijuana Moment, the proposal ‘stipulates that possession of 25 grams or less of cannabis, and the cultivation of up to four plants, would not carry criminal penalties.’ Only one cannabis plant can be dried at any given time according to the petition.

Kasvua Kannabiksesta, the group behind the petition, stated that many of the signatures were obtained close to the deadline. Per Yle:

“People usually leave things to the last minute. We’ve been promoting this recently and getting our message out on social media. There’s certainly more than 50,000 – or even more than 100,000 – people in Finland who support this issue,” Karvinen told Yle on Wednesday evening as the initiative still only had garnered around 41,000 signatures.

Karvinen said decriminalising cannabis is warranted because prohibition of the drug hasn’t worked.

“Primarily, punishing [the use of cannabis] does more harm than good. It promotes social exclusion and [convictions for cannabis possession] can hinder a person’s access to jobs or study spots,” he explained.

Just because the petition received enough signatures to trigger a review by Finland’s Parliament, it does not mean that what is being proposed will become law in Finland. It would be logical for Finland to get on the right side of history and adopt the sensible proposal, however, only time will tell if that proves to be the case.

As of this blog post, the petition has received over 57,000 signatures. You can read the content of the petition at this link here.

The SAFE Banking Act Would Be A Game-Changer For Banking Technology

In order for the U.S. cannabis industry to reach its full potential, it needs access to the nation’s banking system at the same level that other legal industries have. Because the international banking system is so closely tied to the U.S. banking system, cannabis industries in other nations need banking reform to occur in the U.S. just as badly as the U.S. cannabis industry.

Right now a bill is being considered by the United States Senate that would provide comprehensive banking reform for the emerging cannabis industry. The Secure and Fair Enforcement (SAFE) Banking Act of 2019 has already passed in the United States House. It is expected that President Trump would sign the legislation if it made it to his desk.

If the SAFE Banking Act passes and becomes law, it will do more than just allow cannabis companies to make deposits into checking accounts. The reform measure would be a game-changer for technologies that are geared towards supporting the banking industry.

Read more in our article published by Cannabis & Tech Today.

Two New Polls Find Super-Majority Support For U.S. Cannabis Legalization

Cannabis was first prohibited at the federal level in the United States in 1937. For several decades cannabis was prohibited everywhere in the U.S. That changed in 1996 when California voters approved a medical cannabis legalization initiative, which made California the first state to end cannabis prohibition for some of its citizens.

Since the successful vote in California in 1996 several other states have also legalized cannabis for medical use. In 2012 two states, Colorado and Washington State, voted to legalize cannabis for adult use.

Zoom forward to 2019 and dozens of states have legalized cannabis for medical use and nearly a dozen states have legalized cannabis for adult-use. Washington D.C. has legalized cannabis for both medical and adult use. More states appear to be on their way to being added to one or both lists.

Results for two new polls were released this week which found super-majorities for ending cannabis prohibition at the federal level in the U.S. The first was a poll conducted by PRRI, which determined the following:

Americans are broadly supportive of several issues that are championed by leading Democratic candidates: making college tuition free at public institutions (68%), making recreational use of marijuana legal (67%), and a “Medicare for All” plan that would replace private health insurance with government-backed health insurance coverage for all Americans (63%). About one in three Americans strongly favor each of these proposals.

It is worth noting that cannabis legalization is a bipartisan issue now, and is being championed by lawmakers on both ends of the political spectrum. The second poll results were released by Gallup, which has asked U.S. voters every year if they support cannabis legalization, going all the way back to 1969. Per Gallup’s 2019 poll result release:

Americans’ support for legalizing marijuana has held steady at 66% over the past year, after rising 30 percentage points between 2005 and 2018.

The latest results are based on Gallup’s annual Crime survey, conducted Oct. 1-13. Not only have 66% favored legalizing marijuana in the 2018 and 2019 Crime polls, but the same level of support was found in an intervening Gallup survey, conducted in May.

In Gallup’s first poll conducted on this subject in 1969, only 12% of U.S. voters stated that they supported federal legalization. With more states getting on the right side of history and support for federal legalization remaining strong, these poll results should serve as validation that U.S. voters consider state-level cannabis legalization to be working.